Dronabinol
Product Images NDC 42858-869

5 FDA label images from Rhodes Pharmaceuticals Llc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Dronabinol (NDC 42858-869). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rhodes Pharmaceuticals Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Dronabinol 01)

Chemical Structure (Dronabinol 01)
Chemical structure of the active ingredient Dronabinol, as depicted in the diagram showing its molecular arrangement with labeled functional groups.*
FDA Label Image

Figure (Dronabinol 02)

Figure (Dronabinol 02)
A line graph showing mean appetite change from baseline over 6 weeks comparing Dronabinol 2.5 mg BID versus placebo. The vertical axis measures appetite change in mm VAS, and the horizontal axis measures time in weeks. Dronabinol shows a higher increase in appetite over time compared to placebo, with statistical significance indicated at weeks 4 and 6.*
FDA Label Image

Principal Display Panel (2.5 mg Capsule Bottle Label)

Principal Display Panel (2.5 mg Capsule Bottle Label)
Label of Dronabinol Capsules USP showing 2.5 mg strength in a package containing 60 capsules. The label includes a barcode, the proprietary name DRONABINOL, and the statement 'Rx only'. It instructs to dispense the accompanying medication guide to each patient and states the labeler as Rhodes Pharmaceuticals LLC.*
FDA Label Image

Principal Display Panel (5 mg Capsule Bottle Label)

Principal Display Panel (5 mg Capsule Bottle Label)
Dronabinol Capsules, USP 5 mg label from Rhodes Pharmaceuticals LLC. The label indicates 60 capsules per package, with a prescription (Rx) only status. It includes a barcode, NDC number 42858-868-06, and dosage instructions in fine print on the right side of the label.*
FDA Label Image

Principal Display Panel (10 mg Capsule Bottle Label)

Principal Display Panel (10 mg Capsule Bottle Label)
Label for Dronabinol Capsules, USP 10 mg, produced by Rhodes Pharmaceuticals LLC. The label includes the NDC number, a barcode, dosage strength, and instructions to dispense the accompanying medication guide to each patient. It also lists storage information and manufacturer details.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.